Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Oncuria™
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Nonagen BioSci
Type:
CE Marked
Details
Evidence
News
Search handles
Search handles
Filter by
Latest
over1year
Urine-based #bladdercancer diagnosis-BlaDimiR (miRNAs) promising-University Hospital 12 de Octubre, Madrid-cytology is conventional-ImmunoCyt, UroVysion, BTA stat, NMP22 seldom used? Emerging-utDNA, Oncuria? #DrHidekiFuruya @CSCancerCare https://t.co/SEm8tAOSZ2 @practiceupdate ()
over 1 year ago
Clinical
|
Oncuria™ • UroVysion™ Bladder Cancer Kit (UroVysion Kit)
almost2years
#NonagenBioscience announces CE mark for #Oncuria #BladderCancer diagnostic https://t.co/9COwboUvLj ()
almost 2 years ago
Oncuria™
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login